Universal Vision Biotechnology Co., Ltd. (TPEX:3218)
Taiwan · Delayed Price · Currency is TWD 137.00
0.00 (0.00%)
Sep 8, 2026, 12:18 PM CST
TPEX:3218 Market Cap
TPEX:3218 has a market cap or net worth of 11.61 billion as of September 4, 2026. Its market cap has decreased by -23.46% in one year.
Market Cap
11.61B
Enterprise Value
12.12B
Revenue
4.27B
Ranking
n/a
PE Ratio
10.18
Stock Price
137.00
ChartMarket Cap Chart
Since November 3, 2008, TPEX:3218's market cap has increased from 1.01B to 11.61B, an increase of 1,054.47%. That is a compound annual growth rate of 14.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 11.61B | -6.16% |
| Dec 31, 2025 | 12.37B | -27.00% |
| Dec 31, 2024 | 16.94B | -27.80% |
| Dec 29, 2023 | 23.47B | -1.63% |
| Dec 30, 2022 | 23.86B | 10.75% |
| Dec 30, 2021 | 21.54B | 18.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 542.91B |
| Caliway Biopharmaceuticals | 134.39B |
| Lin BioScience | 120.65B |
| Pell Bio-Med Technology | 97.62B |
| Grape King Bio | 13.41B |
| Excelsior Medical | 13.36B |
| Lumosa Therapeutics | 13.35B |
| TaiDoc Technology | 13.15B |